To document the impact of JAK2 mutation on hemoglobin (Hb) level in patients with IMF.
Material and Methods:Thirty five patients were studied out of which 19 were JAK2 positive and16 were JAK2 negative. Sample collection technique was purposive non-probability sampling. Variations were observed among the studied JAK2 positive and JAK2 negative patients regarding hemoglobin level.
Results:In JAK2 positive and negative patients mean hemoglobin level was 10.6g/dl and 8.6g/dl respectively (p=0.29).
Conclusion:Due to the better hemoglobin level, patients with JAK2 mutation have less transfusion requirements and are partially protected against severe anemias compared to patients with no mutation.